Bausch Health Cos Pre-Tax Profit Margin 2010-2024 | BHC
Bausch Health Cos pre-tax profit margin from 2010 to 2024. Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.
| Bausch Health Cos Pre-Tax Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Pre-Tax Income |
Pre-Tax Margin |
| 2024-09-30 |
$9.47B |
$-0.05B |
-0.52% |
| 2024-06-30 |
$9.20B |
$-0.35B |
-3.85% |
| 2024-03-31 |
$8.97B |
$-0.32B |
-3.60% |
| 2023-12-31 |
$8.76B |
$-0.39B |
-4.45% |
| 2023-09-30 |
$8.54B |
$-0.74B |
-8.66% |
| 2023-06-30 |
$8.35B |
$0.03B |
0.30% |
| 2023-03-31 |
$8.15B |
$-0.18B |
-2.25% |
| 2022-12-31 |
$8.12B |
$-0.13B |
-1.59% |
| 2022-09-30 |
$8.13B |
$0.25B |
3.06% |
| 2022-06-30 |
$8.19B |
$0.03B |
0.32% |
| 2022-03-31 |
$8.33B |
$-0.52B |
-6.19% |
| 2021-12-31 |
$8.43B |
$-1.02B |
-12.14% |
| 2021-09-30 |
$8.45B |
$-1.44B |
-17.03% |
| 2021-06-30 |
$8.48B |
$-1.58B |
-18.64% |
| 2021-03-31 |
$8.04B |
$-1.35B |
-16.75% |
| 2020-12-31 |
$8.03B |
$-0.93B |
-11.64% |
| 2020-09-30 |
$8.04B |
$-2.01B |
-25.01% |
| 2020-06-30 |
$8.11B |
$-2.15B |
-26.53% |
| 2020-03-31 |
$8.60B |
$-1.89B |
-22.02% |
| 2019-12-31 |
$8.60B |
$-1.84B |
-21.36% |
| 2019-09-30 |
$8.50B |
$-0.79B |
-9.33% |
| 2019-06-30 |
$8.43B |
$-1.03B |
-12.19% |
| 2019-03-31 |
$8.40B |
$-1.58B |
-18.83% |
| 2018-12-31 |
$8.38B |
$-4.15B |
-49.57% |
| 2018-09-30 |
$8.42B |
$-4.53B |
-53.81% |
| 2018-06-30 |
$8.51B |
$-4.63B |
-54.46% |
| 2018-03-31 |
$8.61B |
$-4.14B |
-48.08% |
| 2017-12-31 |
$8.72B |
$-1.74B |
-19.96% |
| 2017-09-30 |
$8.96B |
$-1.30B |
-14.47% |
| 2017-06-30 |
$9.22B |
$-2.23B |
-24.17% |
| 2017-03-31 |
$9.41B |
$-2.36B |
-25.12% |
| 2016-12-31 |
$9.67B |
$-2.44B |
-25.17% |
| 2016-09-30 |
$10.03B |
$-2.34B |
-23.36% |
| 2016-06-30 |
$10.34B |
$-1.02B |
-9.84% |
| 2016-03-31 |
$10.65B |
$-0.71B |
-6.62% |
| 2015-12-31 |
$10.45B |
$-0.16B |
-1.49% |
| 2015-09-30 |
$9.91B |
$0.66B |
6.70% |
| 2015-06-30 |
$9.18B |
$1.05B |
11.40% |
| 2015-03-31 |
$8.49B |
$1.23B |
14.52% |
| 2014-12-31 |
$8.21B |
$1.06B |
12.86% |
| 2014-09-30 |
$8.05B |
$0.43B |
5.28% |
| 2014-06-30 |
$7.53B |
$-1.09B |
-14.51% |
| 2014-03-31 |
$6.59B |
$-1.25B |
-19.03% |
| 2013-12-31 |
$5.77B |
$-1.31B |
-22.77% |
| 2013-09-30 |
$4.63B |
$-1.51B |
-32.66% |
| 2013-06-30 |
$3.97B |
$-0.46B |
-11.57% |
| 2013-03-31 |
$3.69B |
$-0.44B |
-11.81% |
| 2012-12-31 |
$3.48B |
$-0.39B |
-11.32% |
| 2012-09-30 |
$3.21B |
$-0.20B |
-6.10% |
| 2012-06-30 |
$2.93B |
$-0.10B |
-3.24% |
| 2012-03-31 |
$2.72B |
$-0.03B |
-1.25% |
| 2011-12-31 |
$2.43B |
$-0.02B |
-0.74% |
| 2011-09-30 |
$2.29B |
$-0.08B |
-3.28% |
| 2011-06-30 |
$1.90B |
$-0.24B |
-12.39% |
| 2011-03-31 |
$1.53B |
$-0.24B |
-15.72% |
| 2010-12-31 |
$1.18B |
$-0.24B |
-20.05% |
| 2010-09-30 |
$0.91B |
$-0.06B |
-6.06% |
| 2010-06-30 |
$0.91B |
$0.14B |
15.44% |
| 2010-03-31 |
$0.87B |
$0.13B |
14.98% |
| 2009-12-31 |
$0.82B |
$0.18B |
21.32% |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$2.672B |
$8.757B |
|
Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology.
|
